Skip Navigation
Skip to contents

JPTM : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Previous issues

Page Path
HOME > Articles and issues > Previous issues
12 Previous issues
Filter
Filter
Article category
Keywords
Authors
Funded articles
Volume 50(1); January 2016
Prev issue Next issue
Reviews
Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives
Yoon Young Choi, Sung Hoon Noh, Jae-Ho Cheong
J Pathol Transl Med. 2016;50(1):1-9.   Published online October 26, 2015
DOI: https://doi.org/10.4132/jptm.2015.09.10
  • 11,058 View
  • 143 Download
  • 19 Citations
AbstractAbstract PDF
Gastric cancer is a global health burden and has the highest incidence in East Asia. This disease is complex in nature because it arises from multiple interactions of genetic, local environmental, and host factors, resulting in biological heterogeneity. This genetic intricacy converges on molecular characteristics reflecting the pathophysiology, tumor biology, and clinical outcome. Therefore, understanding the molecular characteristics at a genomic level is pivotal to improving the clinical care of patients with gastric cancer. A recent landmark study, The Cancer Genome Atlas (TCGA) project, showed the molecular landscape of gastric cancer through a comprehensive molecular evaluation of 295 primary gastric cancers. The proposed molecular classification divided gastric cancer into four subtypes: Epstein-Barr virus–positive, microsatellite unstable, genomic stable, and chromosomal instability. This information will be taken into account in future clinical trials and will be translated into clinical therapeutic decisions. To fully realize the clinical benefit, many challenges must be overcome. Rapid growth of high-throughput biology and functional validation of molecular targets will further deepen our knowledge of molecular dimensions of this cancer, allowing for personalized precision medicine.

Citations

Citations to this article as recorded by  
  • Research Progress of MSI Gastric Cancer Subtypes
    成菊 马
    Advances in Clinical Medicine.2022; 12(07): 6719.     CrossRef
  • OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome
    Jaishree Pandian, Ponmathi Panneerpandian, Balaji T. Sekar, Karthikeyan Selvarasu, Kumaresan Ganesan
    Functional & Integrative Genomics.2022; 22(6): 1345.     CrossRef
  • Secondary Primary Cancer after Primary Gastric Cancer: Literature Review and Big Data Analysis Using the Health Insurance Review and Assessment Service (HIRA) Database of Republic of Korea
    Jeong Ho Song, Yeonkyoung Lee, Jaesung Heo, Sang-Yong Son, Hoon Hur, Sang-Uk Han
    Cancers.2022; 14(24): 6165.     CrossRef
  • Microsatellite instability: a review of what the oncologist should know
    Kai Li, Haiqing Luo, Lianfang Huang, Hui Luo, Xiao Zhu
    Cancer Cell International.2020;[Epub]     CrossRef
  • Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial
    Chul Kyu Roh, Yoon Young Choi, Seohee Choi, Won Jun Seo, Minah Cho, Eunji Jang, Taeil Son, Hyoung-Il Kim, Hyeseon Kim, Woo Jin Hyung, Yong-Min Huh, Sung Hoon Noh, Jae-Ho Cheong
    Yonsei Medical Journal.2019; 60(2): 132.     CrossRef
  • Ten Thousand Consecutive Gastrectomies for Gastric Cancer: Perspectives of a Master Surgeon
    Yoon Young Choi, Minah Cho, In Gyu Kwon, Taeil Son, Hyoung-Il Kim, Seung Ho Choi, Jae-Ho Cheong, Woo Jin Hyung
    Yonsei Medical Journal.2019; 60(3): 235.     CrossRef
  • Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer
    Yujun Park, Jiwon Koh, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
    Cancer Immunology, Immunotherapy.2019; 68(11): 1779.     CrossRef
  • Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric Cancer
    Mengsha Tong, Chunyu Yu, Jinwen Shi, Wenwen Huang, Sai Ge, Mingwei Liu, Lei Song, Dongdong Zhan, Xia Xia, Wanlin Liu, Jinwen Feng, Wenhao Shi, Jiafu Ji, Jing Gao, Tieliu Shi, Weimin Zhu, Chen Ding, Yi Wang, Fuchu He, Lin Shen, Tingting Li, Jun Qin
    iScience.2019; 22: 44.     CrossRef
  • Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients
    Jiwon Koh, Soo Kyung Nam, Youn Woo Lee, Jin Won Kim, Keun-Wook Lee, Chan-Young Ock, Do-Youn Oh, Sang-Hoon Ahn, Hyung-Ho Kim, Keon-Wook Kang, Woo Ho Kim, Ho-Young Lee, Hye Seung Lee
    Biomolecules.2019; 9(12): 782.     CrossRef
  • Targeted drug delivery of capecitabine to mice xenograft gastric cancer by PAMAM dendrimer nanocarrier
    Sharareh Jafari, Fatemeh Nabavizadeh, Jalal Vahedian, Mehdi Shafie Ardestani, Hedayat Samandari, Ali Zare Mehrjerdi
    african journal of gastroenterology and hepatology.2019; 2(1): 28.     CrossRef
  • New therapeutic options opened by the molecular classification of gastric cancer
    Mihaela Chivu-Economescu, Lilia Matei, Laura G Necula, Denisa L Dragu, Coralia Bleotu, Carmen C Diaconu
    World Journal of Gastroenterology.2018; 24(18): 1942.     CrossRef
  • Proposed Molecular and miRNA Classification of Gastric Cancer
    Lara Alessandrini, Melissa Manchi, Valli De Re, Riccardo Dolcetti, Vincenzo Canzonieri
    International Journal of Molecular Sciences.2018; 19(6): 1683.     CrossRef
  • High serum MMP-14 predicts worse survival in gastric cancer
    Aaro Kasurinen, Taina Tervahartiala, Alli Laitinen, Arto Kokkola, Timo Sorsa, Camilla Böckelman, Caj Haglund, Dajun Deng
    PLOS ONE.2018; 13(12): e0208800.     CrossRef
  • miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway
    Jianjun Wang, Yang Jiao, Lunmeng Cui, Lili Jiang
    Bioscience, Biotechnology, and Biochemistry.2017; 81(1): 119.     CrossRef
  • Clinicopathologic implication of meticulous pathologic examination of regional lymph nodes in gastric cancer patients
    Jiwon Koh, Hee Eun Lee, Woo Ho Kim, Hye Seung Lee, Ju-Seog Lee
    PLOS ONE.2017; 12(3): e0174814.     CrossRef
  • Perioperative chemotherapy for resectable gastric cancer – what is the evidence?
    Erling A Bringeland, Hans H Wasmuth, Jon E Grønbech
    Scandinavian Journal of Gastroenterology.2017; 52(6-7): 647.     CrossRef
  • Molecular classifications of gastric cancers: Novel insights and possible future applications
    Silvio Ken Garattini, Debora Basile, Monica Cattaneo, Valentina Fanotto, Elena Ongaro, Marta Bonotto, Francesca V Negri, Rosa Berenato, Paola Ermacora, Giovanni Gerardo Cardellino, Mariella Giovannoni, Nicoletta Pella, Mario Scartozzi, Lorenzo Antonuzzo,
    World Journal of Gastrointestinal Oncology.2017; 9(5): 194.     CrossRef
  • GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis
    Puja Khanna, Pei Jou Chua, Belinda Shu Ee Wong, Changhong Yin, Aye Aye Thike, Wei Keat Wan, Puay Hoon Tan, Gyeong Hun Baeg
    Oncotarget.2017; 8(70): 115370.     CrossRef
  • Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients
    Jiwon Koh, Chan-Young Ock, Jin Won Kim, Soo Kyung Nam, Yoonjin Kwak, Sumi Yun, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
    Oncotarget.2017; 8(16): 26356.     CrossRef
Ménétrier’s Disease: Its Mimickers and Pathogenesis
Won Jae Huh, Robert J. Coffey, Mary Kay Washington
J Pathol Transl Med. 2016;50(1):10-16.   Published online December 18, 2015
DOI: https://doi.org/10.4132/jptm.2015.09.15
  • 16,140 View
  • 254 Download
  • 14 Citations
AbstractAbstract PDF
Ménétrier’s disease is a rare protein-losing hypertrophic gastropathy. Histologically, it can be mistaken for other disorders showing hypertrophic gastropathy. The pathogenesis of Ménétrier’s disease is not fully understood; however, it appears that the epidermal growth factor receptor (EGFR) ligand, transforming growth factor alpha, contributes to the pathogenesis of this disorder. In this review, we will discuss disease entities that can mimic Ménétrier’s disease and the role of EGFR signaling in Ménétrier’s disease.

Citations

Citations to this article as recorded by  
  • Beyond Regulation of Acid Secretion: A Novel Role for Histamine in Gastric Macrophage Differentiation and Function
    Diane Bimczok
    Cellular and Molecular Gastroenterology and Hepatology.2023; 15(1): 277.     CrossRef
  • Upper gastrointestinal bleeding as an unusual manifestation of localized Ménétrier’s disease with an underlying lipoma: A case report
    Michal Kmiecik, Aleksandra Walczak, Pawel Samborski, Jacek Paszkowski, Agnieszka Dobrowolska, Jacek Karczewski, Ewelina Swora-Cwynar
    World Journal of Gastrointestinal Endoscopy.2023; 15(1): 10.     CrossRef
  • Chronic Ménétrier disease leading to gastric cancer in youth
    Bruno Salomão Hirsch, Silvia R. Cardoso, Elisa R. Baba, Diogo T. H. de Moura, Manoel Ernesto P. Gonçalves, Rodrigo S. de P. Rocha, Eduardo G. H. de Moura
    Clinical Endoscopy.2023; 56(1): 125.     CrossRef
  • Menetrier disease and Cytomegalovirus infection in paediatric age: report of three cases and a review of the literature
    Federica Barbati, Edoardo Marrani, Giuseppe Indolfi, Paolo Lionetti, Sandra Trapani
    European Journal of Pediatrics.2021; 180(3): 679.     CrossRef
  • Ménétrier-like disease in a Pointer with concurrent granulomatous gastritis, helicobacteriosis and leishmaniosis: a case report
    E. Lagerstedt, T. Spillmann, N. Airas, L. Solano-Gallego, S. Kilpinen
    BMC Veterinary Research.2021;[Epub]     CrossRef
  • EGF and BMPs Govern Differentiation and Patterning in Human Gastric Glands
    Sarah Wölffling, Alice Anna Daddi, Aki Imai-Matsushima, Kristin Fritsche, Christian Goosmann, Jan Traulsen, Richard Lisle, Monika Schmid, Maria del Mar Reines-Benassar, Lennart Pfannkuch, Volker Brinkmann, Jan Bornschein, Peter Malfertheiner, Jürgen Ordem
    Gastroenterology.2021; 161(2): 623.     CrossRef
  • Diagnosis and Management of Ménétrier Disease in Children: A Case Series Review
    Jasmina Krikilion, Elvira Ingrid Levy, Yvan Vandenplas
    Pediatric Gastroenterology, Hepatology & Nutrition.2021; 24(1): 109.     CrossRef
  • Gastric Mucosal Hypertrophy Masquerading as Metastasis From Neuroendocrine Tumor of the Pancreas Detected on 68Ga-DOTANOC PET/CT
    Dharmender Malik, Ramkumar Elumalai, Ritu Verma, Ethel Shangne Belho, Nikhil Seniaray, Harsh Mahajan
    Clinical Nuclear Medicine.2020; 45(1): 74.     CrossRef
  • Unusual case of adult familial Menetrier disease in siblings
    Emily Brownson, Adrian J Stanley, Prakash Konanahalli, John P Seenan
    BMJ Case Reports.2019; 12(10): e231175.     CrossRef
  • Enfermedad de Ménétrier, reporte de caso (con video)
    Martín Alonso Gómez Zuleta, Oscar Fernando Ruíz Morales, Javier Riveros
    Revista Colombiana de Gastroenterología.2019; 34(2): 190.     CrossRef
  • Atrophic gastritis and chronic diarrhea due to Helicobacter pylori infection in early infancy
    Toshihiko Kakiuchi, Aiko Nakayama, Ryo Shimoda, Muneaki Matsuo
    Medicine.2019; 98(47): e17986.     CrossRef
  • The causes of upper gastrointestinal bleeding and urgent gastroscopy at the Center for Emergency Medicine of the Clinical Center Kragujevac
    Biljana Milojković-Kicevska, Zoran Kovačević, Mirjana Janićijević-Petrović, Katarina Janićijević
    Timocki medicinski glasnik.2019; 44(4): 151.     CrossRef
  • Wnt/β-catenin promotes gastric fundus specification in mice and humans
    Kyle W. McCracken, Eitaro Aihara, Baptiste Martin, Calyn M. Crawford, Taylor Broda, Julie Treguier, Xinghao Zhang, John M. Shannon, Marshall H. Montrose, James M. Wells
    Nature.2017; 541(7636): 182.     CrossRef
  • A SMAD4 mutation indicative of juvenile polyposis syndrome in a family previously diagnosed with Menetrier's disease
    James K. Burmester, Lauren N. Bell, Deanna Cross, Patrick Meyer, Steven H. Yale
    Digestive and Liver Disease.2016; 48(10): 1255.     CrossRef
Idiopathic Noncirrhotic Portal Hypertension: An Appraisal
Hwajeong Lee, Aseeb Ur Rehman, M. Isabel Fiel
J Pathol Transl Med. 2016;50(1):17-25.   Published online November 11, 2015
DOI: https://doi.org/10.4132/jptm.2015.09.23
  • 16,251 View
  • 258 Download
  • 20 Citations
AbstractAbstract PDF
Idiopathic noncirrhotic portal hypertension is a poorly defined clinical condition of unknown etiology. Patients present with signs and symptoms of portal hypertension without evidence of cirrhosis. The disease course appears to be indolent and benign with an overall better outcome than cirrhosis, as long as the complications of portal hypertension are properly managed. This condition has been recognized in different parts of the world in diverse ethnic groups with variable risk factors, resulting in numerous terminologies and lack of standardized diagnostic criteria. Therefore, although the diagnosis of idiopathic noncirrhotic portal hypertension requires clinical exclusion of other conditions that can cause portal hypertension and histopathologic confirmation, this entity is under-recognized clinically as well as pathologically. Recent studies have demonstrated that variable histopathologic entities with different terms likely represent a histologic spectrum of a single entity of which obliterative portal venopathy might be an underlying pathogenesis. This perception calls for standardization of the nomenclature and formulation of widely accepted diagnostic criteria, which will facilitate easier recognition of this disorder and will highlight awareness of this entity.

Citations

Citations to this article as recorded by  
  • Porto-Sinusoidal Vascular Disease: A Concise Updated Summary of Epidemiology, Pathophysiology, Imaging, Clinical Features, and Treatments
    Su Jin Jin, Won-Mook Choi
    Korean Journal of Radiology.2023; 24(1): 31.     CrossRef
  • Aetiology and clinical outcomes of non-cirrhotic portal hypertension in Singapore
    PikEu Jason Chang, KimJun Kevin Teh, Mithun Sharma
    Singapore Medical Journal.2023;[Epub]     CrossRef
  • Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension
    Katharina Wöran, Georg Semmler, Mathias Jachs, Benedikt Simbrunner, David Josef Maria Bauer, Teresa Binter, Katharina Pomej, Albert Friedrich Stättermayer, Philipp Schwabl, Theresa Bucsics, Rafael Paternostro, Katharina Lampichler, Matthias Pinter, Michae
    Clinical Gastroenterology and Hepatology.2022; 20(2): e251.     CrossRef
  • Porto-sinusoidal vascular disorder
    Andrea De Gottardi, Christine Sempoux, Annalisa Berzigotti
    Journal of Hepatology.2022; 77(4): 1124.     CrossRef
  • Interventional Management of Portal Hypertension in Cancer Patients
    Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore, Juan C. Camacho
    Current Oncology Reports.2022; 24(11): 1461.     CrossRef
  • Pathological and imaging features of idiopathic non-cirrhotic portal hypertension
    Ming-Jie Tan, Hui Liu, Hui-Guo Ding
    World Chinese Journal of Digestology.2022; 30(16): 729.     CrossRef
  • Bioinformatics Analysis of Common Genetic and Molecular Traits and Association of Portal Hypertension with Pulmonary Hypertension
    MingYu Chen, YouPeng Chen, Ikram Ud Din
    Journal of Healthcare Engineering.2022; 2022: 1.     CrossRef
  • Key histopathologic features in idiopathic noncirrhotic portal hypertension: an interobserver agreement study and proposal for diagnostic criteria
    Jiancong Liang, Chanjuan Shi, William D. Dupont, Safia N. Salaria, Won Jae Huh, Hernan Correa, Joseph T. Roland, Roman E. Perri, Mary Kay Washington
    Modern Pathology.2021; 34(3): 592.     CrossRef
  • Histological analyses of trucut liver biopsies from patients with noncirrhotic portal fibrosis and extra-hepatic portal vein obstruction
    ArchanaGeorge Vallonthaiel, Vandana Baloda, Lavleen Singh, Rajni Yadav, Ragini Kilambi, Sudha Battu, Vishnubhatla Sreenivas, Sujoy Pal, SubratK Acharya, Siddhartha DattaGupta, Shalimar, Prasenjit Das
    Indian Journal of Pathology and Microbiology.2021; 64(5): 127.     CrossRef
  • Nodular regenerative hyperplasia – An under-recognized vascular disorder of liver
    Neha Bakshi, Natasha Gulati, Archana Rastogi, Abhijit Chougule, Chhagan Bihari, Ankur Jindal
    Pathology - Research and Practice.2020; 216(4): 152833.     CrossRef
  • Interobserver study on histologic features of idiopathic non-cirrhotic portal hypertension
    Michel Kmeid, Chunlai Zuo, Stephen M. Lagana, Won-Tak Choi, Jingmei Lin, Zhaohai Yang, Xiuli Liu, Maria Westerhoff, M. Isabel Fiel, Kajsa Affolter, Eun-Young K. Choi, Hwajeong Lee
    Diagnostic Pathology.2020;[Epub]     CrossRef
  • Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition
    Maria Guido, Venancio A F Alves, Charles Balabaud, Prithi S Bathal, Paulette Bioulac-Sage, Romano Colombari, James M Crawford, Amar P Dhillon, Linda D Ferrell, Ryan M Gill, Prodromos Hytiroglou, Yasuni Nakanuma, Valerie Paradis, Alberto Quaglia, Pierre E
    Histopathology.2019; 74(2): 219.     CrossRef
  • Idiopathic noncirrhotic portal hypertension
    M. Isabel Fiel, Thomas D. Schiano
    Seminars in Diagnostic Pathology.2019; 36(6): 395.     CrossRef
  • Pathology of idiopathic non-cirrhotic portal hypertension
    Maria Guido, Samantha Sarcognato, Diana Sacchi, Guido Colloredo
    Virchows Archiv.2018; 473(1): 23.     CrossRef
  • Spectrum of histopathological changes in patients with non-cirrhotic portal fibrosis
    Abhijit Chougule, Archana Rastogi, Rakhi Maiwall, Chhagan Bihari, Vikrant Sood, Shiv Kumar Sarin
    Hepatology International.2018; 12(2): 158.     CrossRef
  • Hepatocellular nodules in vascular liver diseases
    Christine Sempoux, Charles Balabaud, Valérie Paradis, Paulette Bioulac-Sage
    Virchows Archiv.2018; 473(1): 33.     CrossRef
  • Systemic lupus erythematosus complicated by noncirrhotic portal hypertension: A case report and review of literature
    Qi-Bin Yang, Yong-Long He, Chun-Mei Peng, Yu-Feng Qing, Qi He, Jing-Guo Zhou
    World Journal of Clinical Cases.2018; 6(13): 688.     CrossRef
  • Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies
    Chunlai Zuo, Vaibhav Chumbalkar, Peter F. Ells, Daniel J. Bonville, Hwajeong Lee
    Hepatology International.2017; 11(5): 452.     CrossRef
  • The pathological differential diagnosis of portal hypertension
    Raouf E. Nakhleh
    Clinical Liver Disease.2017; 10(3): 57.     CrossRef
  • Hepatic vascular diseases
    Naziheh Assarzadegan, Robert A. Anders, Kiyoko Oshima
    Diagnostic Histopathology.2017; 23(12): 553.     CrossRef
Overview of IgG4-Related Tubulointerstitial Nephritis and Its Mimickers
Hyeon Joo Jeong, Su-Jin Shin, Beom Jin Lim
J Pathol Transl Med. 2016;50(1):26-36.   Published online December 14, 2015
DOI: https://doi.org/10.4132/jptm.2015.11.09
  • 9,537 View
  • 201 Download
  • 7 Citations
AbstractAbstract PDF
Tubulointerstitial nephritis (TIN) is the most common form of renal involvement in IgG4-related disease. It is characterized by a dominant infiltrate of IgG4-positive plasma cells in the interstitium and storiform fibrosis. Demonstration of IgG4-positive plasma cells is essential for diagnosis, but the number of IgG4-positive cells and the ratio of IgG4-positive/IgG-positive plasma cells may vary from case to case and depending on the methods of tissue sampling even in the same case. IgG4-positive plasma cells can be seen in TIN associated with systemic lupus erythematosus, Sjögren syndrome, or anti-neutrophil cytoplasmic antibody–associated vasculitis, which further add diagnostic confusion and difficulties. To have a more clear view of IgG4-TIN and to delineate differential points from other TIN with IgG4-positive plasma cell infiltrates, clinical and histological features of IgG4-TIN and its mimickers were reviewed. In the rear part, cases suggesting overlap of IgG4-TIN and its mimickers and glomerulonephritis associated with IgG4-TIN were briefly described.

Citations

Citations to this article as recorded by  
  • Concurrent anti-neutrophil cytoplasmic antibody-associated glomerulonephritis and IgG4-associated tubulointerstitial nephritis with C3 glomerulonephritis
    Jianan Feng, Jinyu Yu, Xueyao Wang, Yue Wang, Yang Liu, Zhonggao Xu, Weixia Sun
    Medicine.2020; 99(5): e18857.     CrossRef
  • A case of eosinophilic granulomatosis with polyangiitis as a mimicker of IgG4-related disease
    Ryuichiro Kanda, Satoshi Kubo, Kazuhisa Nakano, Akio Kawabe, Aya Nawata, Kentaro Hanami, Shingo Nakayamada, Yoshiya Tanaka
    Modern Rheumatology Case Reports.2020; 4(2): 278.     CrossRef
  • Renal tubular acidosis as the initial presentation of Sjögren’s syndrome
    Karen Ho, Pouneh Dokouhaki, Mark McIsaac, Bhanu Prasad
    BMJ Case Reports.2019; 12(8): e230402.     CrossRef
  • Immunoglobulin G4-related kidney diseases: An updated review
    Maurizio Salvadori, Aris Tsalouchos
    World Journal of Nephrology.2018; 7(1): 29.     CrossRef
  • Systemic lupus erythematosus in a patient with an organic lesion of the central nervous system: practicaldifferential diagnosis
    E. V. Lebedeva, M. V. Novoseltsev, A. N. Lvov, I. V. Khamaganova
    Klinicheskaya dermatologiya i venerologiya.2018; 17(6): 21.     CrossRef
  • Concurrent IgG4-related tubulointerstitial nephritis and IgG4 myeloperoxidase-anti-neutrophil cytoplasmic antibody positive crescentic glomerulonephritis
    Tao Su, Li Yang, Zhao Cui, Su-xia Wang, Ming-hui Zhao
    Medicine.2017; 96(20): e6707.     CrossRef
  • IgG4-Related Kidney Disease: Report of a Case Presenting as a Renal Mass
    Daniele Bianchi, Luca Topazio, Gabriele Gaziev, Valerio Iacovelli, Pierluigi Bove, Alessandro Mauriello, Enrico Finazzi Agrò
    Case Reports in Surgery.2017; 2017: 1.     CrossRef
Original Articles
Review of Medical Advisory Services by the Korean Society of Pathologists from 2003 to 2014
Min Hye Jang, Geon Kook Lee, Han Seong Kim, Wan Seop Kim
J Pathol Transl Med. 2016;50(1):37-44.   Published online November 17, 2015
DOI: https://doi.org/10.4132/jptm.2015.09.18
  • 6,900 View
  • 52 Download
AbstractAbstract PDFSupplementary Material
Background
Since 2003, the Korean Society of Pathologists (KSP) has been officially providing medical advisory services (MAS). We reviewed the cases submitted to the KSP between 2003 and 2014. Methods: In total, 1,950 cases were submitted, most by private health insurance companies. The main purposes of the consultations were to clarify the initial diagnoses and to assign a proper disease classification code. We comprehensively reviewed 1,803 consultation cases with detailed information. Results: In spite of some fluctuations, the number of submitted cases has been significantly increasing over the 12 study years. The colon and rectum (40.3%), urinary bladder (14.2%), and stomach (6.9%) were the three most common tissues of origin. The most common diagnoses for each of the three tissues of origin were neuroendocrine tumor (50.7%), non-invasive papillary urothelial carcinoma (70.7%), and adenocarcinoma (36.2%). Regardless of the tissue of origin, neuroendocrine tumor of the digestive system was the most common diagnosis (419 of 1,803). Conclusions: In the current study, we found that pathologic consultations associated with private health insurance accounted for a large proportion of the MAS. Coding of the biologic behavior of diseases was the main issue of the consultations. In spite of the effort of the KSP to set proper guidelines for coding and classification of tumors, this review revealed that problems still exist and will continue to be an important issue.
Eosinophils in Colorectal Neoplasms Associated with Expression of CCL11 and CCL24
Hyuck Cho, Sung-Jig Lim, Kyu Yeoun Won, Go Eun Bae, Gou Young Kim, Ji Won Min, Byeong-joo Noh
J Pathol Transl Med. 2016;50(1):45-51.   Published online December 14, 2015
DOI: https://doi.org/10.4132/jptm.2015.10.16
  • 8,162 View
  • 109 Download
  • 31 Citations
AbstractAbstract PDF
Background
A decrease in the number of tissue eosinophils is known to reflect the malignancy potential of neoplastic lesions and even prognosis. Increased levels of the chemokines CCL11 and CCL24 in serum and tissue are also known to have diagnostic value as serum tumor markers or prognostic factors. The aim of this study was to evaluate the correlation between the degree of tissue eosinophilia and the expression of these chemokines in the glandular and stromal cells of colorectal neoplastic lesions ranging from benign to malignant tumors. Methods: We counted the number of infiltrating eosinophils in neoplastic lesion tissue and we evaluated the expression of CCL11 and CCL24 in glandular cells and stromal cells by immunohistochemical staining. Results: The results showed that the number of eosinophils decreased significantly and the expression of CCL11 and CCL24 in glandular cells decreased with tumor progression, whereas the stromal expression of CCL11 and CCL24 appeared to increase. Conclusions: The discrepancy in CCL11 and CCL24 expression between glandular cells and stromal cells might shed light on how colorectal cancer evades the immune system, which would enable further development of immunotherapies that target these chemokines. Further research on eosinophil biology and the expression pattern of chemokines in tumor cells is needed.

Citations

Citations to this article as recorded by  
  • Eosinophilia in cancer and its regulation by sex hormones
    Sandeep Artham, Ching-Yi Chang, Donald P. McDonnell
    Trends in Endocrinology & Metabolism.2023; 34(1): 5.     CrossRef
  • Systemic Evaluation of the Effect of Diabetes Mellitus on Breast Cancer in a Mouse Model
    Nana Wei, Jinmiao Lu, Zhibing Lin, Xiaoyu Wang, Mengmeng Cai, Shengyao Jiang, Xiaoyu Chen, Shilan Zhu, Dong Zhang, Li Cui
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies
    Medina Mamtimin, Akif Pinarci, Chao Han, Attila Braun, Hans-Joachim Anders, Thomas Gudermann, Elmina Mammadova-Bach
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Immune-Related Biomarkers Associated with Lung Metastasis from the Colorectal Cancer Microenvironment
    Wang Da, Wu Yinhang, Zhuang Jing, Xu Jiamin, Gao Xinyi, Song Yongmao, Pan Yuefen
    Journal of Interferon & Cytokine Research.2022; 42(5): 220.     CrossRef
  • Cancer-Associated Fibroblasts Promote Tumor Aggressiveness in Head and Neck Cancer through Chemokine Ligand 11 and C-C Motif Chemokine Receptor 3 Signaling Circuit
    Wen-Yen Huang, Yaoh-Shiang Lin, Yu-Chun Lin, Shin Nieh, Yi-Ming Chang, Tsai-Yu Lee, Su-Feng Chen, Kuender D. Yang
    Cancers.2022; 14(13): 3141.     CrossRef
  • Eosinophils Decrease Pulmonary Metastatic Mammary Tumor Growth
    Rachel A. Cederberg, Sarah Elizabeth Franks, Brennan J. Wadsworth, Alvina So, Lisa R. Decotret, Michael G. Hall, Rocky Shi, Michael R. Hughes, Kelly M. McNagny, Kevin L. Bennewith
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • An Immune-Related Prognostic Risk Model in Colon Cancer by Bioinformatics Analysis
    Qing Lai, Haifei Feng, Shuli Yang
    Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
  • Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies Using Flow Cytometry
    Nami Tateyama, Teizo Asano, Hiroyuki Suzuki, Guanjie Li, Takeo Yoshikawa, Tomohiro Tanaka, Mika K. Kaneko, Yukinari Kato
    Antibodies.2022; 11(4): 75.     CrossRef
  • Granulocytes and Cells of Granulocyte Origin—The Relevant Players in Colorectal Cancer
    Izabela Siemińska, Ewa Poljańska, Jarek Baran
    International Journal of Molecular Sciences.2021; 22(7): 3801.     CrossRef
  • CCL24 Protects Renal Function by Controlling Inflammation in Podocytes
    Youdi Wang, Xue Wu, Mengya Geng, Jiamin Ding, Kangjia Lv, Hui Du, Jiahui Ding, Wenjun Pei, Xin Hu, Jing Gu, Lizhuo Wang, Yao Zhang, Jialin Gao, Roberta Rizzo
    Disease Markers.2021; 2021: 1.     CrossRef
  • Primary tumors from mucosal barrier organs drive unique eosinophil infiltration patterns and clinical associations
    Sharon Grisaru-Tal, Michal Itan, Daniel G Grass, Javier Torres-Roca, Steven A Eschrich, Yaara Gordon, Avishay Dolitzky, Inbal Hazut, Shmuel Avlas, Elizabeth A Jacobsen, Tomer Ziv-Baran, Ariel Munitz
    OncoImmunology.2021;[Epub]     CrossRef
  • Discovery of core gene families associated with liver metastasis in colorectal cancer and regulatory roles in tumor cell immune infiltration
    Wei-Qing Liu, Wen-Liang Li, Shu-Min Ma, Lei Liang, Zhi-Yong Kou, Jun Yang
    Translational Oncology.2021; 14(3): 101011.     CrossRef
  • Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity
    Sharon Grisaru-Tal, Shai Dulberg, Lir Beck, Chunyan Zhang, Michal Itan, Soroor Hediyeh-zadeh, Julie Caldwell, Perri Rozenberg, Avishay Dolitzky, Shmuel Avlas, Inbal Hazut, Yaara Gordon, Ophir Shani, Shlomo Tsuriel, Motti Gerlic, Neta Erez, Nicolas Jacquel
    Cancer Research.2021; 81(21): 5555.     CrossRef
  • Tumor Immunology and Tumor Evolution: Intertwined Histories
    Jérôme Galon, Daniela Bruni
    Immunity.2020; 52(1): 55.     CrossRef
  • A new dawn for eosinophils in the tumour microenvironment
    Sharon Grisaru-Tal, Michal Itan, Amy D. Klion, Ariel Munitz
    Nature Reviews Cancer.2020; 20(10): 594.     CrossRef
  • Eotaxins and Their Receptor in Colorectal Cancer—A Literature Review
    Monika Zajkowska, Barbara Mroczko
    Cancers.2020; 12(6): 1383.     CrossRef
  • Eosinophilic peritonitis with colon cancer: a case report
    Ryo Ataka, Hirokazu Tanaka, Shintaro Yagi, Kei Yamane, Kenji Yoshino, Tomoyuki Miyauchi, Tomoaki Yoh, Keiichi Arafuka, Shinichi Fujita, Akihiko Hamada, Bunji Endo, Shinji Uemoto
    BMC Gastroenterology.2020;[Epub]     CrossRef
  • Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
    Jan Korbecki, Klaudyna Kojder, Katarzyna Barczak, Donata Simińska, Izabela Gutowska, Dariusz Chlubek, Irena Baranowska-Bosiacka
    International Journal of Molecular Sciences.2020; 21(16): 5647.     CrossRef
  • CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
    Jan Korbecki, Klaudyna Kojder, Donata Simińska, Romuald Bohatyrewicz, Izabela Gutowska, Dariusz Chlubek, Irena Baranowska-Bosiacka
    International Journal of Molecular Sciences.2020; 21(21): 8412.     CrossRef
  • Opposing roles of eosinophils in cancer
    Sonja C. S. Simon, Jochen Utikal, Viktor Umansky
    Cancer Immunology, Immunotherapy.2019; 68(5): 823.     CrossRef
  • Prognostic significance of inflammatory cell response in patients with colorectal cancer
    Katarzyna Jakubowska, Mariusz Koda, Wojciech Kisielewski, Luiza Kańczuga‑Koda, Waldemar Famulski
    Oncology Letters.2019;[Epub]     CrossRef
  • Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer
    Hadar Reichman, Michal Itan, Perri Rozenberg, Tal Yarmolovski, Eli Brazowski, Chen Varol, Nathan Gluck, Shiran Shapira, Nadir Arber, Udi Qimron, Danielle Karo-Atar, James J. Lee, Ariel Munitz
    Cancer Immunology Research.2019; 7(3): 388.     CrossRef
  • Developmental endothelial locus-1 (Del-1) antagonizes Interleukin-17-mediated allergic asthma
    Shu Yan, Li Chen, Qi Zhao, Ya-Nan Liu, Rui Hou, Jing Yu, Hong Zhang
    Immunology and Cell Biology.2018; 96(5): 526.     CrossRef
  • Expression of Galectins-1 and Galectin-3 in Stomach and Colorectal Cancer with Tissue Eosinophilia
    Yu. V. Kolobovnikova, A. I. Dmitrieva, K. I. Yankovich, O. A. Vasil’eva, I. L. Purlik, V. S. Poletika, V. V. Novitskii, O. I. Urazova
    Bulletin of Experimental Biology and Medicine.2018; 165(2): 256.     CrossRef
  • The expression of CCL11/eotaxin, CCR3 receptor and eosinophil peroxidase in tumor tissue in gastric and colon cancers
    Yu. V. Kolobovnikova, K. I. Yankovich, E. V. Romanova, A. I. Dmitrieva, V. V. Novitskiy, O. I. Urazova
    Bulletin of Siberian Medicine.2018; 17(3): 80.     CrossRef
  • Friend or foe?
    Tommaso Colangelo, Giovanna Polcaro, Livio Muccillo, Giovanna D'Agostino, Valeria Rosato, Pamela Ziccardi, Angelo Lupo, Gianluigi Mazzoccoli, Lina Sabatino, Vittorio Colantuoni
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2017; 1867(1): 1.     CrossRef
  • CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis
    Lei Jin, Wei-Ren Liu, Meng-Xin Tian, Xi-Fei Jiang, Han Wang, Pei-Yun Zhou, Zhen-Bin Ding, Yuan-Fei Peng, Zhi Dai, Shuang-Jian Qiu, Jian Zhou, Jia Fan, Ying-Hong Shi
    Oncotarget.2017; 8(3): 5135.     CrossRef
  • Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer
    Susanne Blank, Henrik Nienhüser, Lena Dreikhausen, Leila Sisic, Ulrike Heger, Katja Ott, Thomas Schmidt
    Oncotarget.2017; 8(29): 47518.     CrossRef
  • The formation mechanisms of tumor-associated tissue eosinophilia in gastric cancer and colon cancer
    В.В. Новицкий, К.И. Янкович, Ю.В. Колобовникова, А.И. Дмитриева, О.И. Уразова, И.Л. Пурлик, Л.А. Кудяков, С.П. Чумакова
    ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia».2017; (4(61)): 74.     CrossRef
  • LncRNAs expression in adjuvant-induced arthritis rats reveals the potential role of LncRNAs contributing to rheumatoid arthritis pathogenesis
    Hui Jiang, Xiu-Juan Qin, Wei-Ping Li, Rong Ma, Ting Wang, Zhu-Qing Li
    Gene.2016; 593(1): 131.     CrossRef
  • Emerging Roles for Eosinophils in the Tumor Microenvironment
    Hadar Reichman, Danielle Karo-Atar, Ariel Munitz
    Trends in Cancer.2016; 2(11): 664.     CrossRef
Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
Jong Jin Sung, Sang Jae Noh, Jun Sang Bae, Ho Sung Park, Kyu Yun Jang, Myoung Ja Chung, Woo Sung Moon
J Pathol Transl Med. 2016;50(1):52-57.   Published online November 18, 2015
DOI: https://doi.org/10.4132/jptm.2015.10.09
  • 7,919 View
  • 69 Download
  • 11 Citations
AbstractAbstract PDF
Background
Increasing evidence has shown that tumor initiation and growth are nourished by a small subpopulation of cancer stem cells (CSCs) within the tumor mass. CSCs are posited to be responsible for tumor maintenance, growth, distant metastasis, and relapse after curative operation. We examined the expression of CSC markers in paraffin-embedded tissue sections of hepatocellular carcinoma (HCC) and correlated the results with clinicopathologic characteristics. Methods: Immunohistochemical staining for the markers believed to be expressed in the CSCs, including epithelial cell adhesion molecule (EpCAM), keratin 19 (K19), CD133, and CD56, was performed in 82 HCC specimens. Results: EpCAM expression was observed in 56% of the HCCs (46/82) and K19 in 6% (5/82). EpCAM expression in HCC significantly correlated with elevated α-fetoprotein level, microvessel invasion of tumor cells, and high histologic grade. In addition, Ep- CAM expression significantly correlated with K19 expression. The overall survival and relapsefree survival rates in patients with EpCAM-expressing HCC were relatively lower than those in patients with EpCAM-negative HCC. All but two of the 82 HCCs were negative for CD133 and CD56, respectively. Conclusions: Our results suggest that HCCs expressing EpCAM are associated with unfavorable prognostic factors and have a more aggressive clinical course than those not expressing EpCAM. Further, the expression of either CD133 or CD56 in paraffin-embedded HCC tissues appears to be rare.

Citations

Citations to this article as recorded by  
  • The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers
    Izabela Zarębska, Arkadiusz Gzil, Justyna Durślewicz, Damian Jaworski, Paulina Antosik, Navid Ahmadi, Marta Smolińska-Świtała, Dariusz Grzanka, Łukasz Szylberg
    Clinics and Research in Hepatology and Gastroenterology.2021; 45(3): 101664.     CrossRef
  • Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
    Zhouhong Ge, Jean C.A. Helmijr, Maurice P.H.M. Jansen, Patrick P.C. Boor, Lisanne Noordam, Maikel Peppelenbosch, Jaap Kwekkeboom, Jaco Kraan, Dave Sprengers
    Translational Oncology.2021; 14(7): 101073.     CrossRef
  • Hepatocellular Carcinoma Score and Subclassification Into Aggressive Subtypes Using Immunohistochemical Expression of p53, β-Catenin, CD133, and Ki-67
    Asmaa G. Abdou, Nanis S. Holah, Dina S. Elazab, Walaa G. El-Gendy, Mohammed T. Badr, Dalia R. Al-Sharaky
    Applied Immunohistochemistry & Molecular Morphology.2021; 29(1): 20.     CrossRef
  • The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma
    Keigo Murakami, Hiroyuki Kumata, Shigehito Miyagi, Takashi Kamei, Hironobu Sasano
    Pathology International.2021; 71(10): 682.     CrossRef
  • Predictors of recurrence and survival of hepatocellular carcinoma: A prospective study including transient elastography and cancer stem cell markers
    Hend Ibrahim Shousha, Rabab Fouad, Tamer Mahmoud Elbaz, Dina Sabry, Mohamed Mahmoud Nabeel, Ahmed Hosni Abdelmaksoud, Aisha Mahmoud Elsharkawy, Zeinab Abdellatif Soliman, Ghada Habib, Ashraf Omar Abdelaziz
    Arab Journal of Gastroenterology.2020; 21(2): 95.     CrossRef
  • Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
    Ya Li, Qiuju Han, Huajun Zhao, Quanjuan Guo, Jian Zhang
    Frontiers in Pharmacology.2020;[Epub]     CrossRef
  • The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations
    An B. Luong, Huy Q. Do, Paola Tarchi, Deborah Bonazza, Cristina Bottin, Loraine Kay D. Cabral, Long D. C. Tran, Thao P. T. Doan, Lory S. Crocè, Hoa L. T. Pham, Claudio Tiribelli, Caecilia H. C. Sukowati
    Cells.2020; 9(12): 2672.     CrossRef
  • Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma
    Hirohisa Okabe, Tomoharu Yoshizumi, Yo-ichi Yamashita, Katsunori Imai, Hiromitsu Hayashi, Shigeki Nakagawa, Shinji Itoh, Norifumi Harimoto, Toru Ikegami, Hideaki Uchiyama, Toru Beppu, Shinichi Aishima, Ken Shirabe, Hideo Baba, Yoshihiko Maehara, Motoyuki
    PLOS ONE.2018; 13(9): e0203856.     CrossRef
  • Overexpression of epithelial cell adhesion molecule as a predictor of poor outcome in patients with hepatocellular carcinoma
    Chih‑Jan Ko, Chia‑Jung Li, Meng‑Yu Wu, Pei‑Yi Chu
    Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
  • Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
    Wanlu Li, Mi-Ra Lee, EunHee Choi, Mee-Yon Cho
    Journal of Pathology and Translational Medicine.2017; 51(1): 17.     CrossRef
  • PIN1 in hepatocellular carcinoma is associated with TP53 gene status
    Jun Sang Bae, Sang Jae Noh, Kyoung Min Kim, Kyu Yun Jang, Ho Sung Park, Myoung Ja Chung, Byung-Hyun Park, Woo Sung Moon
    Oncology Reports.2016; 36(4): 2405.     CrossRef
Evaluation of the VE1 Antibody in Thyroid Cytology Using Ex Vivo Papillary Thyroid Carcinoma Specimens
Yon Hee Kim, Hyunee Yim, Yong-Hee Lee, Jae Ho Han, Kyi Beom Lee, Jeonghun Lee, Euy Young Soh, Seon-Yong Jeong, Jang-Hee Kim
J Pathol Transl Med. 2016;50(1):58-66.   Published online December 14, 2015
DOI: https://doi.org/10.4132/jptm.2015.10.10
  • 8,440 View
  • 70 Download
  • 8 Citations
AbstractAbstract PDF
Background
Recently, VE1, a monoclonal antibody against the BRAFV600E mutant protein, has been investigated in terms of its detection of the BRAFV600E mutation. Although VE1 immunostaining and molecular methods used to assess papillary thyroid carcinoma in surgical specimens are in good agreement, evaluation of VE1 in thyroid cytology samples is rarely performed, and its diagnostic value in cytology has not been well established. In present study, we explored VE1 immunoexpression in cytology samples from ex vivo papillary thyroid carcinoma specimens in order to minimize limitations of low cellularity and sampling/targeting errors originated from thyroid fineneedle aspiration and compared our results with those obtained using the corresponding papillary thyroid carcinoma tissues. Methods: The VE1 antibody was evaluated in 21 cases of thyroid cytology obtained directly from ex vivo thyroid specimens. VE1 immunostaining was performed using liquid-based cytology, and the results were compared with those obtained using the corresponding tissues. Results: Of 21 cases, 19 classic papillary thyroid carcinomas had BRAFV600E mutations, whereas two follicular variants expressed wild-type BRAF. VE1 immunoexpression varied according to specimen type. In detection of the BRAFV600E mutation, VE1 immunostaining of the surgical specimen exhibited 100% sensitivity and 100% specificity, whereas VE1 immunostaining of the cytology specimen exhibited only 94.7% sensitivity and 0% specificity. Conclusions: Our data suggest that VE1 immunostaining of a cytology specimen is less specific than that of a surgical specimen for detection of the BRAFV600E mutation, and that VE1 immunostaining of a cytology specimen should be further evaluated and optimized for clinical use.

Citations

Citations to this article as recorded by  
  • VE1 immunohistochemistry is an adjunct tool for detection of BRAF V600E mutation: Validation in thyroid cancer patients
    Faiza A. Rashid, Sobia Tabassum, Mosin S. Khan, Hifzur R. Ansari, Muhammad Asif, Ahmareen K. Sheikh, Syed Aga
    Journal of Clinical Laboratory Analysis.2021;[Epub]     CrossRef
  • Effective utilization of liquid-based cytology for thyroid lesions
    Yukie YAMAYA
    The Journal of the Japanese Society of Clinical Cytology.2021; 60(3): 164.     CrossRef
  • Diagnostic efficacy of brafv600e immunocytochemistry in thyroid aspirates in bethesda category iv and papillary thyroid carcinoma
    Nidhi Anand, Tushar Agrawal, Anurag Gupta, Saumya Shukla, Roma Pradhan, Nuzhat Husain
    Journal of Cytology.2021; 38(3): 113.     CrossRef
  • The immunocytochemical expression ofVE‐1 (BRAFV600E‐related) antibody identifies the aggressive variants of papillary thyroid carcinoma on liquid‐based cytology
    Patrizia Straccia, Chiara Brunelli, Esther D. Rossi, Paola Lanza, Maurizio Martini, Teresa Musarra, Celestino Pio Lombardi, Alfredo Pontecorvi, Guido Fadda
    Cytopathology.2019; 30(5): 460.     CrossRef
  • Utility of the BRAF p.V600E immunoperoxidase stain in FNA direct smears and cell block preparations from patients with thyroid carcinoma
    Amber L. Smith, Michelle D. Williams, John Stewart, Wei-Lien Wang, Savitri Krishnamurthy, Maria E. Cabanillas, Sinchita Roy-Chowdhuri
    Cancer Cytopathology.2018; 126(6): 406.     CrossRef
  • Refinement of the criteria for ultrastructural peritubular capillary basement membrane multilayering in the diagnosis of chronic active/acute antibody-mediated rejection
    Heounjeong Go, Sung Shin, Young Hoon Kim, Duck Jong Han, Yong Mee Cho
    Transplant International.2017; 30(4): 398.     CrossRef
  • Thyroid Fine-Needle Aspiration Cytology Practice in Korea
    Yoon Jin Cha, Ju Yeon Pyo, SoonWon Hong, Jae Yeon Seok, Kyung-Ju Kim, Jee-Young Han, Jeong Mo Bae, Hyeong Ju Kwon, Yeejeong Kim, Kyueng-Whan Min, Soonae Oak, Sunhee Chang
    Journal of Pathology and Translational Medicine.2017; 51(6): 521.     CrossRef
  • Use of monoclonal antibodies to detect specific mutations in formalin-fixed, paraffin-embedded tissue sections
    Zhenying Guo, Ricardo V. Lloyd
    Human Pathology.2016; 53: 168.     CrossRef
Case Studies
IgG4-Related Disease Presented as a Mural Mass in the Stomach
Chang Gok Woo, Jeong Hwan Yook, Ah Young Kim, Jihun Kim
J Pathol Transl Med. 2016;50(1):67-70.   Published online September 30, 2015
DOI: https://doi.org/10.4132/jptm.2015.07.28
  • 7,513 View
  • 79 Download
  • 20 Citations
AbstractAbstract PDF
Isolated gastric IgG4-related disease (IgG4-RD) is a very rare tumefactive inflammatory condition, with only a few cases reported to date. A 48-year-old woman was incidentally found to have a subepithelial tumor in the stomach. Given a presumptive diagnosis of gastrointestinal stromal tumor or neuroendocrine tumor, she underwent wedge resection. The lesion was vaguely nodular and mainly involved the submucosa and proper muscle layer. Microscopically, all classical features of type I autoimmune pancreatitis including lymphoplasmacytic infiltration, storiform fibrosis, obliterative phlebitis, and numerous IgG4-positive plasma cells were seen. She had no evidence of IgG4-RD in other organs. Although very rare, IgG4-RD should be considered one of the differential diagnoses in the setting of gastric wall thickening or subepithelial mass-like lesion. Deep biopsy with awareness of this entity might avoid unnecessary surgical intervention.

Citations

Citations to this article as recorded by  
  • IgG4-related pseudotumours: a series of 12 cases and a review of the literature
    Andrea Maccagno, Bianca Grosser, László Füzesi, Björn Konukiewitz, Dmytro Vlasenko, Dorothea Weckermann, Stephan Raab, Johannes Zenk, Abbas Agaimy, Bruno Märkl
    Pathology.2022; 54(5): 563.     CrossRef
  • IgG4-Related Disease With Gastrointestinal Involvement: Case Reports and Literature Review
    Xinhe Zhang, Xing Jin, Lin Guan, Xuyong Lin, Xuedan Li, Yiling Li
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Clinicopathological characteristics of gastric IgG4‐related disease: Systematic scoping review
    Haruki Sawada, Torrey Czech, Krixie Silangcruz, Landon Kozai, Adham Obeidat, Eric Andrew Wien, Midori Filiz Nishimura, Asami Nishikori, Yasuharu Sato, Yoshito Nishimura
    Journal of Gastroenterology and Hepatology.2022; 37(10): 1865.     CrossRef
  • Utility of gastric biopsy in diagnosing IgG4‐related gastrointestinal disease
    Kaori Uchino, Kenji Notohara, Takeshi Uehara, Yasuhiro Kuraishi, Junya Itakura, Akihiro Matsukawa
    Pathology International.2021; 71(2): 124.     CrossRef
  • A reappraisal of sclerosing nodular and/or polypoid lesions of the gastrointestinal tract rich in IgG4‐positive plasma cells
    Runjan Chetty
    Histopathology.2020; 76(6): 832.     CrossRef
  • Gastric IgG4-related disease presenting as a mass lesion and masquerading as a gastrointestinal stromal tumor
    Banumathi Ramakrishna, Rohan Yewale, Kavita Vijayakumar, Patta Radhakrishna, Balakrishnan Siddartha Ramakrishna
    Journal of Pathology and Translational Medicine.2020; 54(3): 258.     CrossRef
  • IgG4-related Sclerosing Disease Forming a Gastric Submucosal Tumor Diagnosed after Laparoscopic Endoscopic Cooperative Surgery—Report of a Case—
    Tatsuki ISHIKAWA, Katsunori NAKANO, Masafumi OSAKA, Yayoi KADOTANI, Kaori OKUGAWA, Kiyokazu AKIOKA, Kenta SHIGEMORI, Yohei HOSOKAWA
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2020; 81(2): 254.     CrossRef
  • Calcifying fibrous tumor of the gastrointestinal tract: A clinicopathologic review and update
    Donald Turbiville, Xu-Chen Zhang
    World Journal of Gastroenterology.2020; 26(37): 5597.     CrossRef
  • A Suspected Case of IgG4-Related Appendiceal Pseudotumor
    Yudai Hojo, Yoshiharu Shirakata, Ai Izumi, Jun Matsui, Tokuyuki Yamashita, Hikaru Aoki, Makoto Kurimoto, Masaaki Hirata, Naoki Goda, Hiroaki Ito, Jun Tamura
    The Japanese Journal of Gastroenterological Surgery.2020; 53(12): 976.     CrossRef
  • Immunoglobulin G4-related gastric pseudotumor – An impostor: Case report
    Manuel Santiago Mosquera, Andrea Suarez Gómez, Hugo Herrera, Karen Moreno-Medina, Alejandro González-Orozco, Carlos J-Perez Rivera
    International Journal of Surgery Case Reports.2020; 75: 333.     CrossRef
  • Imaging and pathological features of gastric lesion of immunoglobulin G4-related disease: A case report and review of the recent literature
    Dai Inoue, Norihide Yoneda, Kotaro Yoshida, Hiromi Nuka, Jun Kinoshita, Sachio Fushida, Fumihito Toshima, Tetsuya Minami, Masayuki Takahira, Shoko Hamaoka, Hiroko Ikeda, Toshifumi Gabata, Mitsuhiro Kawano
    Modern Rheumatology.2019; 29(2): 377.     CrossRef
  • Immunoglobulin G4-Related Gastric Ulcer Mimicking Advanced Stomach Cancer in a Patient with Type I Autoimmune Pancreatitis
    Joung Ha Park, Jin Hee Noh, Jang ho Lee, Goeun Lee, Seung-Mo Hong, Kwang Bum Cho, Myung-Hwan Kim
    The Korean Journal of Medicine.2019; 94(3): 287.     CrossRef
  • Review of IgG4-related disease
    Raquel Sánchez-Oro, Elsa María Alonso-Muñoz, Lidia Martí Romero
    Gastroenterología y Hepatología (English Edition).2019; 42(10): 638.     CrossRef
  • Revisión de la enfermedad relacionada con la IgG4
    Raquel Sánchez-Oro, Elsa María Alonso-Muñoz, Lidia Martí Romero
    Gastroenterología y Hepatología.2019; 42(10): 638.     CrossRef
  • Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey
    Kenji Notohara, Terumi Kamisawa, Kazushige Uchida, Yoh Zen, Mitsuhiro Kawano, Satomi Kasashima, Yasuharu Sato, Masahiro Shiokawa, Takeshi Uehara, Hajime Yoshifuji, Hiroko Hayashi, Koichi Inoue, Keisuke Iwasaki, Hiroo Kawano, Hiroyuki Matsubayashi, Yukitos
    Journal of Gastroenterology.2018; 53(7): 845.     CrossRef
  • IgG4-Related Disease Mimicking Crohn’s Disease: A Case Report and Review of Literature
    Fabiana Ciccone, Antonio Ciccone, Mirko Di Ruscio, Filippo Vernia, Gianluca Cipolloni, Gino Coletti, Giuseppe Calvisi, Giuseppe Frieri, Giovanni Latella
    Digestive Diseases and Sciences.2018; 63(4): 1072.     CrossRef
  • IgG4-related Disease in the Stomach which Was Confused with Gastrointestinal Stromal Tumor (GIST): Two Case Reports and Review of the Literature
    Ho Seok Seo, Yoon Ju Jung, Cho Hyun Park, Kyo Young Song, Eun Sun Jung
    Journal of Gastric Cancer.2018; 18(1): 99.     CrossRef
  • Multivisceral IgG4-related disease presenting as recurrent massive gastrointestinal bleeding: a case report and literature review
    Xuexue Deng, Ronghua Fang, Jianshu Zhang, Rongqiong Li
    BMC Gastroenterology.2018;[Epub]     CrossRef
  • IgG4-Related Sclerosing Disease Presenting as a Gastric Submucosal Tumor
    Takashi Masuda, Toshifumi Matsumoto, Yushi Kaishakuji, Hirotada Tajiri, Akinori Egashira, Hirofumi Kawanaka
    The Japanese Journal of Gastroenterological Surgery.2018; 51(10): 599.     CrossRef
  • A rare case of IgG4-related disease: a gastric mass, associated with regional lymphadenopathy
    Dimitar Bulanov, Elena Arabadzhieva, Sasho Bonev, Atanas Yonkov, Diana Kyoseva, Tihomir Dikov, Violeta Dimitrova
    BMC Surgery.2016;[Epub]     CrossRef
Gastric-Type Extremely Well-Differentiated Adenocarcinoma of the Stomach: A Challenge for Preoperative Diagnosis
Mee Joo, Song Hee Han
J Pathol Transl Med. 2016;50(1):71-74.   Published online September 30, 2015
DOI: https://doi.org/10.4132/jptm.2015.07.14
  • 9,622 View
  • 131 Download
  • 5 Citations
AbstractAbstract PDF
Gastric-type extremely well-differentiated adenocarcinoma (EWDA) is a rare type of gastric adenocarcinoma characterized by infiltration of well-formed mucinous glands with little or no nuclear atypia, which resemble foveolar epithelium or pyloric glands. Because of its high degree of differentiation, preoperative biopsy diagnosis of gastric-type EWDA is very difficult. We encountered a case of gastric-type EWDA, manifesting as a Borrmann type 4 lesion, in a 47-year-old man. Despite four repeated biopsies, the preoperative biopsy diagnosis was not conclusive due to the scarcity of diagnostic tumor cells and lack of knowledge regarding the unusual histologic findings of gastric-type EWDA. We herein describe the histologic findings of gastric-type EWDA in detail, with the aim of facilitating a preoperative biopsy diagnosis and understanding of this rare type of gastric adenocarcinoma.

Citations

Citations to this article as recorded by  
  • Extremely well-differentiated adenocarcinoma of the stomach: diagnostic pitfalls in endoscopic biopsy
    Jongwon Lee, In-Seob Lee, Ji Yong Ahn, Young Soo Park, Jihun Kim
    Journal of Pathology and Translational Medicine.2022; 56(2): 63.     CrossRef
  • Helicobacter pylori-negative Gastric Cancer
    Sun-Young Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(1): 10.     CrossRef
  • Preoperative diagnosis of a gastric extremely well-differentiated adenocarcinoma: A case report
    Katsushi Suenaga, Shiro Matsumoto, Alan Kawarai Lefor, Yoshimasa Miura, Yoshinori Hosoya, Daigo Kuboki, Hidenori Haruta, Kentaro Kurashina, Atsushi Kihara, Daisuke Matsubara, Yasunari Sakuma, Joji Kitayama, Naohiro Sata
    International Journal of Surgery Case Reports.2020; 73: 319.     CrossRef
  • Gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection
    Chengfang Li, Xinglong Wu, Shuang Yang, Xiaorong Yang, Jin Yao, Hong Zheng
    Diagnostic Pathology.2020;[Epub]     CrossRef
  • Gastric Adenocarcinoma of the Fundic Gland Type
    Mark A Benedict, Gregory Y Lauwers, Dhanpat Jain
    American Journal of Clinical Pathology.2018; 149(6): 461.     CrossRef
Brief Case Reports
Double Para-testicular Cellular Angiofibroma and Synchronous Testicular Microlithiasis
Seungkoo Lee, Hyuck Jae Choi
J Pathol Transl Med. 2016;50(1):75-77.   Published online July 29, 2015
DOI: https://doi.org/10.4132/jptm.2015.06.23
  • 7,061 View
  • 69 Download
  • 2 Citations
PDF

Citations

Citations to this article as recorded by  
  • A report of a patient presenting with three metachronous 13q14LOH mesenchymal tumours: spindle cell lipoma, cellular angiofibroma and mammary myofibroblastoma
    Andrea Cordaro, Harry R. Haynes, Timothy Murigu, Michael Michal, Francesca Maggiani, Demetris Poyiatzis, Abigail Palmer, Zsombor Melegh
    Virchows Archiv.2021; 479(3): 631.     CrossRef
  • Role of calcifying nanoparticles in the development of testicular microlithiasis in vivo
    Xia-cong Lin, Xiang Gao, Gen-sheng Lu, Bo Song, Qing-hua Zhang
    BMC Urology.2017;[Epub]     CrossRef
Indeterminate Dendritic Cell Tumor: A Case Report of a Rare Langerhans Cell Lineage Disease
Jin Roh, So-Woon Kim, Chan-Sik Park
J Pathol Transl Med. 2016;50(1):78-81.   Published online August 4, 2015
DOI: https://doi.org/10.4132/jptm.2015.07.03
  • 8,560 View
  • 103 Download
  • 6 Citations
PDF

Citations

Citations to this article as recorded by  
  • Neoplasias de células histiocitarias y dendríticas: revisión de la literatura
    Cristina Díaz del Arco, Luis Ortega Medina, M. Jesús Fernández Aceñero
    Revista Española de Patología.2018; 51(3): 160.     CrossRef
  • Indeterminate cell histiocytosis in a Chinese patient with progressive and extensive nodular lesions and mixed indeterminate cell and macrophage-monocyte lineage
    Qiping Chen, Joyce S.-S. Lee, Michelle W. Liang, Michelle M.F. Chan, Ramón M. Pujol, Luis Requena, Suat Hoon Tan
    Journal of Cutaneous Pathology.2018; 45(6): 428.     CrossRef
  • Recurrent Indeterminate Dendritic Cell Tumor of the Skin
    Jin Woo Joo, Taek Chung, Yoon Ah Cho, Sang Kyum Kim
    Journal of Pathology and Translational Medicine.2018; 52(4): 243.     CrossRef
  • Indeterminate Dendritic Cell Tumor: A Report of Two New Cases Lacking the ETV3-NCOA2 Translocation and a Literature Review
    Jonathan J. Davick, Jinah Kim, Mark R. Wick, Alejandro A. Gru
    The American Journal of Dermatopathology.2018; 40(10): 736.     CrossRef
  • A Case of Indeterminate Dendritic Cell Tumor: A Rare Neoplasm with Langerhans Cell Lineage
    Jungyoon Moon, Ji Hoon Yang, Jaewon Lee, Jong Seo Park, Kwang Hyun Cho
    Annals of Dermatology.2018; 30(6): 744.     CrossRef
  • Indeterminate Dendritic Cell Tumor in Thoracic Spine: A Case Report
    Sze Kiat Tan, Lee Onn Chieng, Karthik Madhavan, Andrew Rosenberg, Ian Cote
    World Neurosurgery.2017; 108: 543.     CrossRef

JPTM : Journal of Pathology and Translational Medicine